Low-Frequency Repetitive Transcranial Magnetic Stimulation to the Temporoparietal Junction for Tinnitus; Four-Week Stimulation Trial

Piccirillo JF, Kallogjeri D, Nicklaus J, Wineland A, Spitznagel EL, Vlassenko AG, Benzinger TLS, Mathews J, Garcia KS. ; Arch Otolaryngol Head Neck Surg 2013; 139: 388-395. Read More


Importance This research examines the impact of 4 weeks of repetitive transcranial magnetic stimulation (rTMS) stimulation to the temporoparietal junction and compares the results of this longer duration of treatment with a similar stimulus protocol of only 2 weeks’ duration.

Objective To examine the effectiveness and safety of 4 weeks of low-frequency rTMS to the left temporoparietal junction in a cohort of patients with bothersome tinnitus.

Design Crossover, double-blind, randomized controlled trial.

Setting Outpatient academic medical center.

Participants The study population comprised 14 adults aged between 22 and 59 years with subjective, unilateral or bilateral, nonpulsatile tinnitus of 6 months’ duration or greater and a score of 34 or greater on the Tinnitus Handicap Inventory (THI).

Interventions Low-frequency (1 Hz) 110% motor threshold rTMS or sham to the left temporoparietal junction for 4 weeks.
Main Outcome and Measure The difference of the change in the THI score between active rTMS and sham rTMS.

Results Active treatment was associated with a median reduction in THI score of 10 (range, −20 to +4) points, and sham treatment was associated with a median reduction of 6 (range, −24 to +12) points. The median difference in THI score between the change associated with active and sham rTMS was 4 (95% CI, −9 to 10; and range, −32 to +14) points.

Conclusions and Relevance Daily low-frequency active rTMS to the left temporoparietal junction area for 4 weeks was no more effective than sham for patients with chronic bothersome tinnitus. Possible explanations for this negative study include the failure of rTMS to stimulate deeper parts of auditory cortex within the sylvian fissure and more widespread cortical network changes not amenable to localized rTMS effects.

Trial Registration clinicaltrials.gov Identifier: NCT00567892

Full Text


Posted on February 11, 2014
Posted in: HPAN, Neurodegeneration, Publications Authors: